ArthroCare
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
ArthroCare (NASDAQ: ARTC) is a
ENT
.
Controversies
In 2008, several class actions were filed against ArthroCare, alleging that ArthroCare issued materially false and misleading statements and failed to disclose some adverse facts. In 2012, a settlement of $74 million was approved.[2]
References
- ^ Dealbook (18 August 2009). "One Equity Partners has signed an agreement with ArthroCare that will provide the latter with a $75 million infusion". The New York Times. Retrieved 2011-04-01.
- ^ "Class Action Lawsuit Against ArthroCare". Archived from the original on 2013-06-19.
External links